• Eldecalcitol Suppresses Endothelial Ferroptosis in Diabetic

  2026-07-29

  This study identifies eldecalcitol as a regulator of endothelial ferroptosis in type 2 diabetic osteoporosis, acting via the SOCE/O-GlcNAcylation axis. The findings clarify how metabolic stress impacts bone health through vascular mechanisms, suggesting novel therapeutic targets for diabetic bone disease.

• IEM 1460: Redefining AMPA Blockade for Translational Neuropr

  2026-07-28

  This thought-leadership article explores IEM 1460, a selective AMPA receptor blocker from APExBIO, as a transformative tool for translational neuroscience. We integrate mechanistic insights on AMPA-mediated excitotoxicity, evidence from related glutamate antagonist studies, and strategic recommendations for assay design and workflow optimization. By situating IEM 1460 at the intersection of molecular pharmacology and preclinical neuroprotection, we provide advanced guidance for researchers aiming to bridge in vitro discoveries with translational impact.

• Fluconazole for Fungal Cytochrome P450 Inhibition: Applied W

  2026-07-28

  Fluconazole stands apart as a gold-standard fungal cytochrome P450 enzyme 14α-demethylase inhibitor, enabling both robust antifungal susceptibility testing and advanced modeling of drug resistance. This article delivers protocol refinements, troubleshooting strategies, and translational insights—bridging breakthrough host-pathogen research and practical antifungal assay design.

• MK-571 (L-660,711): Strategic Leverage in Inflammation & Res

  2026-07-27

  This thought-leadership article explores the dual mechanistic and translational relevance of MK-571 (L-660,711) in leukotriene-mediated inflammation and multidrug resistance research. Drawing on recent breakthroughs in immune cell preservation, it provides actionable protocol guidance and strategic insight for translational researchers seeking to optimize assay design and bridge preclinical findings to clinical promise.

• Rhodamine B: Quantitative Tracing for Pesticide Drift Analys

  2026-07-27

  Rhodamine B (Basic Violet 10) transforms environmental spray drift assessment and cell imaging, offering unmatched solubility and fluorescence sensitivity. This article bridges UAV field tracing, protocol optimization, and workflow troubleshooting, empowering researchers to generate robust, reproducible data across environmental and biological contexts.

• Honokiol in Advanced In Vitro Cancer Drug Response Modeling

  2026-07-26

  Explore how Honokiol, a potent NF-κB pathway inhibitor, enables nuanced in vitro modeling of cancer drug responses. This article uniquely bridges biomolecular mechanism with protocol optimization, offering actionable insights for advanced inflammation and oncology research.

• Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Cell Dea

  2026-07-25

  The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, stage-specific detection of apoptosis in cell populations. This kit distinguishes early and late apoptotic states using dual fluorescent markers, supporting high-confidence flow cytometry apoptosis detection. APExBIO's K2003 kit facilitates reproducible, quantitative research in cancer and drug resistance studies.

• PPT (Propyl Pyrazole Triol): Precision Tools for ERα Pathway

  2026-07-24

  Explore how PPT (Propyl Pyrazole Triol), a potent and selective ERα agonist, is revolutionizing estrogen receptor signaling research. This article reveals advanced protocols, mechanistic insights, and practical assay considerations, distinct from existing content.

• Axitinib (AG 013736): Quantitative Angiogenesis Inhibition i

  2026-07-24

  Discover how Axitinib (AG 013736) transforms angiogenesis inhibition assays and tumor xenograft studies with quantitative rigor. This article explores advanced assay design, referencing pivotal research and providing unique insights for cancer biology researchers.

• Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal

  2026-07-23

  Neticonazole Hydrochloride stands at the intersection of mycology and oncology, enabling high-reproducibility antifungal and cancer research with a single compound. Its dual mechanism—targeting fungal membranes and modulating exosome secretion—allows translational researchers to streamline experimental workflows and tackle both cutaneous candidiasis and colorectal cancer models.

• C8-HSL Drives Lung Cancer Cell Proliferation via PI3K/AKT/ER

  2026-07-23

  This study reveals that N-octanoyl-L-Homoserine lactone (C8-HSL), a bacterial quorum-sensing molecule, enhances lung cancer cell proliferation, migration, and invasion by activating the PI3K/AKT/ERK pathway. The findings establish a mechanistic connection between Gram-negative microbial signaling and lung tumor progression, offering new directions for microbial pathogenicity and infection biology research.

• SM-102: Bridging Mechanism and Strategy in mRNA Delivery

  2026-07-22

  This deep-dive explores the mechanistic and translational frontiers of SM-102—heptadecan-9-yl 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)octanoate—as a key enabler of mRNA therapeutics. Drawing on recent evidence in tumor suppressor replacement and comparative analyses of mRNA delivery systems, the article provides strategic guidance for translational researchers seeking to unlock the full potential of lipid nanoparticles.

• SB743921: Applied Workflows for Kinesin Spindle Protein Inhi

  2026-07-22

  SB743921 empowers cancer researchers with high-precision mitotic arrest, enabling clear dissection of proliferation versus cell death. This article guides you through advanced experimental workflows, troubleshooting, and data-driven insights to maximize the reproducibility and interpretability of anti-cancer assays with this selective KSP inhibitor.

• Deracoxib: Advancing COX-2 Inhibition in Translational Oncol

  2026-07-21

  This thought-leadership article explores the strategic and mechanistic role of Deracoxib—a selective COX-2 inhibitor—in contemporary translational research. Bridging robust evidence from cancer biology, inflammation assays, and cell viability studies, it provides actionable guidance for experimental design, highlights synergy with combination therapies, and positions Deracoxib (SKU B1091) as a pivotal tool for next-generation veterinary and comparative oncology workflows.

• BML-277: Potent Chk2 Inhibitor for DNA Damage Response Resea

  2026-07-21

  BML-277 is a highly selective Chk2 inhibitor with nanomolar potency, enabling precise interrogation of DNA damage checkpoints and radioprotection of T-cells. Its ATP-competitive mechanism and strong selectivity profile make it a valuable tool for mechanistic studies in cancer and genome stability research.

455 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page